Sutro Works Toward A Better Ovarian Cancer ADC
Readies Next Asset For The Clinic
Sutro Biopharma CEO Bill Newell spoke with Scrip about the company’s novel platform, its goal of improving folate receptor alpha-driven ovarian cancer and its business development strategy.
